Trials / Terminated
TerminatedNCT01100866
Study of POMELLA™ Extract to Treat Prostate Cancer
Randomized Controlled Trial of POMELLA™ Extract in Prostate Cancer Patients Scheduled for Surgery
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Vancouver Coastal Health · Other Government
- Sex
- Male
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, two-arm, placebo controlled trial to evaluate benefit of treatment using POMELLA™ extract on mechanisms known to drive prostate cancer. This research allows provision for biochemical and histological comparisons to be made between POMELLA™ treated and placebo treated prostate tissues removed from men with organ confined prostate cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | POMELLA™ (pomegranate extract) | in a capsule form, 2 x 500mg once daily |
| OTHER | Placebo | placebo capsules |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2010-04-09
- Last updated
- 2014-03-11
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01100866. Inclusion in this directory is not an endorsement.